Compare Humana Inc (HUM) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Kimberly Clark Corp — how do they compare? Humana Inc trades at $437.41 (market cap $47.61B), while Kimberly Clark Corp trades at $97.57 (market cap $32.09B). The key difference: Humana Inc is the larger of the two by market cap, and Kimberly Clark Corp pays the higher dividend (5.31%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Kimberly Clark Corp for 93 Days on average.
| HUM | KMB | |
|---|---|---|
Market Cap | $47.61B | $32.09B |
Volume | 1,827,332 | 2,800,459 |
Sector | Health | Consumer Staples |
52-Week High | $409.85 | $121.44 |
52-Week Low | $163.67 | $93.05 |
Typical Hold Time | 53 Days | 93 Days |
Enterprise Value | $54.97B | $37.65B |
Dividend Yield | 0.89% | 5.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Kimberly-Clark (KMB) trades at $97.74, up 1.0% on the day, with a bearish technical signal but strong dividend yield of 5.16%. Recent earnings show a mix of beats and a Q2 2026 miss, while the pending Kenvue acquisition and executive transitions dominate news. The stock is undervalued relative to its consensus price target of $117.25, with a P/E of 19.07 and robust profitability metrics including a net income margin of 11.79%.
KMB offers a high dividend yield and valuation upside, but risks include integration challenges from the Kenvue deal, cash flow pressures, and bearish technical trends. Analyst consensus is cautious with 61% hold ratings, reflecting concerns over execution and sustainability of the dividend amid acquisition-related liabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
